Nowadays, it is basically not seen by doctors to go to the hospital for medical treatment. The diagnosis is first, blood tests and urine tests have become commonplace, and these tests are based on in vitro diagnostic reagents. In vitro diagnostic reagents also occupy an increasingly important position in the entire medical process with its accuracy, ease and efficiency. In modern medical systems, not only can the workload of doctors be greatly reduced, but also the diagnosis can be greatly improved. The accuracy and preventiveness of the disease, therefore, in vitro diagnosis has the reputation of "doctor's glasses." Therefore, in vitro diagnostic reagents have a huge demand market in major hospital clinics, and eventually the rapid development of China's in vitro diagnostic industry (IVD). According to the Statistical Analysis of the "Blue Book of Chinese Medicine Health" published by the China Pharmaceutical Industry Information Center (hereinafter collectively referred to as the "Blue Book"): In 2014, the market size of China's in vitro diagnostic products reached 30.6 billion yuan; it is expected that the market size will reach 72.3 billion yuan in 2019. The annual average growth rate is as high as 18.7%. 1. Connotation and market classification In vitro diagnostic products include reagent instruments and analytical systems for collecting, preparing (directing), and detecting human body samples (including body fluids, cells, tissue samples, etc.). In general, the in vitro diagnostic market is divided into four major categories: biochemical reagents, immunodiagnosis, molecular diagnostics, and real-time testing (POCT). According to the "Blue Book" data: In 2014, the in vitro diagnostic segment accounted for the top three in the overall market ratio: nearly 40% of the immunodiagnosis (38%), nearly 20% of the biochemical reagents (19%) and accounted for The ratio is 15% molecular diagnosis. At present, the largest share of market share is immunodiagnosis. Among them, biochemical reagent products are mainly domestic brands; immunodiagnostic products are dominated by imports, domestic brands occupy a certain share; molecular diagnostic products are mixed with imported and domestic brands; and in POCT products, imports are The main and domestic are still in their infancy. Sarms Tablets,High Purity Mk--2866,Medical Grade Sarrms Mk 2866,Muscle Bodybuilding Shaanxi Hongbaiyi Biotech Co., Ltd. , https://www.sxhongbaiyi.com